课件：KDIGO肾小球疾病的免疫治疗新进展.ppt

We suggest that a relapse of LN after complete or partial remission be treated by the original regimen that was used to induce the remission (2B) If resuming original therapy would result in excessive lifetime CYC exposure we suggest a non-CYC initial regimen (2B) Consider a repeat kidney biopsy during relapse if there is suspicion that the histologic class of LN has changed, or there is uncertainty as to the level of active disease versus chronicity (not graded) We suggest that a relapse of LN after complete or partial remission be treated by the original regimen that was used to induce the